Skip to main content

Crescent Biopharma, Inc 10-K for FY2020

Crescent Biopharma, Inc. (CBIO)

10-K 2021-03-02 For: 2020-12-31
View Original
Added on April 10, 2026

About this 10-K

Crescent Biopharma, Inc filed this 10-K on March 2, 2021, covering the fiscal year ended December 31, 2020 (FY2020).

Headline figures

Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$10.16M
Net loss
$51.03M
compared with a net loss of $57.89M a year earlier